Composite likelihood method for inferring local pedigrees

por Ko, Amy, Nielsen, Rasmus
Publicado 2017

Robust Analysis of Fluxes in Genome-Scale Metabolic Pathways

por MacGillivray, Michael, Ko, Amy, Gruber, Emily, Sawyer, Miranda, Almaas, Eivind, Holder, Allen
Publicado 2017

Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]

por Curtis, Sean P, Bockow, Barry, Fisher, Chester, Olaleye, Joseph, Compton, Amy, Ko, Amy T, Reicin, Alise S
Publicado 2005

The treatment patterns, efficacy, and safety of nab(®)-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis

por Liang, Caihua, Li, Ling, Fraser, Cindy Duval, Ko, Amy, Corzo, Deyanira, Enger, Cheryl, Patt, Debra
Publicado 2015

The POU Factor Ventral Veins Lacking/Drifter Directs the Timing of Metamorphosis through Ecdysteroid and Juvenile Hormone Signaling

por Cheng, CeCe, Ko, Amy, Chaieb, Leila, Koyama, Takashi, Sarwar, Prioty, Mirth, Christen K., Smith, Wendy A., Suzuki, Yuichiro
Publicado 2014

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial

por Gridelli, Cesare, Chen, Tianlei, Ko, Amy, O’Brien, Mary E, Ong, Teng Jin, Socinski, Mark A, Postmus, Pieter E
Publicado 2018

The history and evolution of the Denisovan-EPAS1 haplotype in Tibetans

por Zhang, Xinjun, Witt, Kelsey E., Bañuelos, Mayra M., Ko, Amy, Yuan, Kai, Xu, Shuhua, Nielsen, Rasmus, Huerta-Sanchez, Emilia
Publicado 2021

Archaic Adaptive Introgression in TBX15/WARS2

por Racimo, Fernando, Gokhman, David, Fumagalli, Matteo, Ko, Amy, Hansen, Torben, Moltke, Ida, Albrechtsen, Anders, Carmel, Liran, Huerta-Sánchez, Emilia, Nielsen, Rasmus
Publicado 2017

Use of a digital contact tracing system in Singapore to mitigate COVID-19 spread

por Chow, Bryan W. K., Lim, Yi Ding, Poh, Richard C. H., Ko, Amy, Hong, Guo Hao, Zou, Steffen W. L., Cheah, Joshua, Ho, Shaowei, Lee, Vernon J. M., Ho, Marc Z. J.
Publicado 2023

Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer...

por Yardley, Denise A., Brufsky, Adam, Coleman, Robert E., Conte, Pierfranco F., Cortes, Javier, Glück, Stefan, Nabholtz, Jean-Mark A., O’Shaughnessy, Joyce, Beck, Robert M., Ko, Amy, Renschler, Markus F., Barton, Debora, Harbeck, Nadia
Publicado 2015

Erratum to: ‘Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative b...

por Yardley, Denise A., Brufsky, Adam, Coleman, Robert E., Conte, Pierfranco F., Cortes, Javier, Glück, Stefan, Nabholtz, Jean-Mark A., O’Shaughnessy, Joyce, Beck, Robert M., Ko, Amy, Renschler, Markus F., Barton, Debora, Harbeck, Nadia
Publicado 2016

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy

por Thomas, Michael, Spigel, David R, Jotte, Robert M, McCleod, Michael, Socinski, Mark A, Page, Ray D, Gressot, Laurent, Knoble, Jeanna, Juan, Oscar, Morgensztern, Daniel, Isla, Dolores, Kim, Edward S, West, Howard, Ko, Amy, Ong, Teng Jin, Trunova, Nataliya, Gridelli, Cesare
Publicado 2017